DevonScottConwayMDMS

PubMed

• Progressive Encephalomyelopathy in an Older Man: A Case Report From the National Multiple Sclerosis Society Case Conference Proceedings.
  Lindsay A Ross, Jonathan Lee, Alise K Carlson, Devon S Conway, Jeffrey A Cohen, Jennifer Graves, Scott S Zamvil, Scott D Newsome, Amy Kunchok> ;Neurology(R) Neuroimmunology & Neuroinflammation. 2024 May 1
• Extended interval dosing of natalizumab: More evidence in support.
  Karlo Toljan, Devon S Conway> ;Neurotherapeutics. 2024 Mar 25
• Health, Wellness, and the Effect of Comorbidities on the Multiple Sclerosis Disease Course: Tackling the Modifiable.
  Devon S Conway, Amy B Sullivan, Mary Rensel> ;Neurologic Clinics. 2024 Feb 1
• Predicting disability and mortality in CV2/CRMP5-IgG associated paraneoplastic neurologic disorders.
  Sanem P Uysal, Yadi Li, Nicolas R Thompson, Alex Milinovich, Justin R Abbatemarco, Jeffrey A Cohen, Devon S Conway, Daniel Ontaneda, John A Morren, Amy Kunchok> ;Annals of Clinical and Translational Neurology. 2024 Mar 1
• Common Social and Health Disparities Contribute to Racial Differences in Ambulatory Impairment in Multiple Sclerosis.
  Briggs, F., Trapl, E., Nadai, A., Gunzler, D., Mateen, F., Conway, D.> ;International Journal of MS Care. 2024 Jan 5
• 1 citations
  Detecting isolated cognitive relapses in persons with MS.
  Sarah A Morrow, Zachary L Weinstock, Omid Mirmosayyeb, Devon Conway, Tom Fuchs, Michael G Jaworski, Sveltlana Eckert, David H Hojnacki, Michael G Dwyer, Robert Zivadin...> ;Multiple Sclerosis. 2023 Dec 1
• 1 citations
  The impact of cigarette smoking on cognitive processing speed and brain atrophy in multiple sclerosis.
  Ebtesam Alshehri, Jeffrey A Cohen, Daniel Ontaneda, Kunio Nakamura, Scott Husak, Thomas E Love, Robert J Fox, Farren Bs Briggs, Devon S Conway> ;Multiple Sclerosis. 2023 Jun 1
• 4 citations
  The relationship between cognition, education, and employment in multiple sclerosis patients.
  Devon S Conway, Robert A Bermel, Sarah M Planchon> ;Multiple Sclerosis Journal - Experimental, Translational and Clinical. 2022 Aug 5
• 20 citations
  Interpreting change on the Symbol Digit Modalities Test in people with relapsing multiple sclerosis using the reliable change methodology.
  Zachary Weinstock, Sarah A. Morrow, Devon S. Conway, Tom A. Fuchs, Curtis Wojcik, Robert Zivadinov, Bianca Weinstock-Guttman, Grant L. Iverson, Michael G. Dwyer, Ralph...> ;Multiple Sclerosis. 2021 Oct 6
• 1 citations
  Comorbidities require special attention in minorities with multiple sclerosis
  Devon S. Conway, Claudia H Marck> ;Multiple Sclerosis. 2021 Aug 27
• 4 citations
  Characterizing relapsing remitting multiple sclerosis patients burdened with hypertension, hyperlipidemia, and asthma.
  Alena Sorensen, Devon S. Conway, Farren B.S. Briggs> ;Multiple Sclerosis and Related Disorders. 2021 May 21
• 1 citations
  Integrating patient-reported outcomes and quantitative timed tasks to identify relapsing remitting multiple sclerosis patient subgroups: a latent profile analysis.
  Farren B.S. Briggs, Devon S. Conway, Alessandro S. De Nadai, Daniel Ontaneda, Douglas D. Gunzler> ;Multiple Sclerosis and Related Disorders. 2021 Mar 18
• 2 citations
  Age of hypertension onset in multiple sclerosis patients.
  Farren B.S. Briggs, Diane Krill, Eddie Hill, Devon S. Conway> ;Multiple Sclerosis. 2021 Mar 18
• 15 citations
  Vascular comorbidity is associated with lower brain volumes and lower neuroperformance in a large multiple sclerosis cohort
  Kathryn C. Fitzgerald, Anne Damian, Devon S. Conway, Ellen M. Mowry> ;Multiple Sclerosis. 2021 Jan 8
• 6 citations
  Measures of Thalamic Integrity are Associated with Cognitive Functioning in Fingolimod-treated Multiple Sclerosis Patients
  Devon S. Conway, Sarah M. Planchon, Se-Hong Oh, Kunio Nakamura, Nicolas R. Thompson, Kenneth Earl Sakaie, Daniel Ontaneda> ;Multiple Sclerosis and Related Disorders. 2021 Jan 1
• 14 citations
  Quantifying cognition and fatigue to enhance the sensitivity of the EDSS during relapses.
  Sarah A. Morrow, Devon S. Conway, Tom A. Fuchs, Curtis Wojcik, Faizan Yasin, Jeta Pol, Sveltlana Eckert, David Hojnacki, Michael G. Dwyer, Robert Zivadinov, Bianca Wei...> ;Multiple Sclerosis. 2021 Jun 1
• 50 citations
  Safety and efficacy of MD1003 (high-dose biotin) in patients with progressive multiple sclerosis (SPI2): a randomised, double-blind, placebo-controlled, phase 3 trial.
  Bruce A.C. Cree, Gary Cutter, Jerry S. Wolinsky, M. S. Freedman, Giancarlo Comi, Gavin Giovannoni, Hans-Peter Hartung, Douglas L. Arnold, Jens Kuhle, Valerie J Block, ...> ;The Lancet. Neurology. 2020 Dec 1
• 2 citations
  Does obesity exacerbate brain lesion volume and atrophy in patients with multiple sclerosis
  Rachel Galioto, Ophira Berenholz, Zhini Wang, Devon S. Conway, Sarah M. Planchon, Stephen M. Rao> ;Multiple Sclerosis and Related Disorders. 2020 Sep 10
• 8 citations
  Comorbidity effect on processing speed test and MRI measures in multiple sclerosis patients.
  Justin R. Abbatemarco, Daniel Ontaneda, Kunio Nakamura, Scott Husak, Zhini Wang, Ebtesam Alshehri, Robert A. Bermel, Devon S. Conway> ;Multiple Sclerosis and Related Disorders. 2020 Oct 21
• 4 citations
  Effect of tobacco use on disease activity and DMT discontinuation in multiple sclerosis patients treated with dimethyl fumarate or fingolimod.
  Carrie M. Hersh, Haleigh Harris, Malissa Ayers, Devon S. Conway> ;Multiple Sclerosis Journal - Experimental, Translational and Clinical. 2020 Oct 13
• 2 citations
  Is Obesity Related to Processing Speed Impairment in Patients with Multiple Sclerosis: Results of a Large-Scale, Multicenter Study
  Rachel Galioto, Devon S. Conway, Sarah M. Planchon, Stephen M. Rao> ;Archives of Clinical Neuropsychology. 2020 Jul 24
• 9 citations
  Patient reported outcomes and performance metrics at diagnosis of secondary progressive multiple sclerosis.
  Devon S. Conway, Nicolas R. Thompson, Xiangyi Meng, Kristen Johnson, Robert J. Fox> ;Multiple Sclerosis. 2021 Apr 1
• 12 citations
  Technology-enabled assessments to enhance multiple sclerosis clinical care and research.
  Gabrielle Macaron, Brandon P Moss, Hong Li, Laura E. Baldassari, Stephen M. Rao, David Schindler, Jay L. Alberts, Malory Weber, Malissa Ayers, Francois Bethoux, Adrien...> ;Neurology. Clinical Practice. 2020 Jun 1
• Impact of Switching to Fingolimod Versus Injectable Disease-Modifying Therapy Cycling on Risk of Multiple Sclerosis-Related Relapses: A Retrospective Analysis.
  Maria Cecilia Vieira, Yunfeng Li, Xiangyi Meng, Huanxue Zhou, Olivia Wenxian Piao, Christen Kutz, Devon S. Conway> ;International Journal of MS Care. 2021 Mar 1
• 1 citations
  Disease activity outcomes with different washout periods after switching from natalizumab to an alternative disease-modifying therapy.
  Le H. Hua, Haleigh Harris, Devon S. Conway, Carrie M. Hersh> ;Journal of Neurology. 2020 Apr 9
• Join now to see all